FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1483092803> ?p ?o ?g. }

• W1483092803 endingPage "124" @default.
• W1483092803 startingPage "115" @default.
• W1483092803 abstract "1 The uptake, metabolism and biliary excretion of the cysteinyl leukotrienes LTC4, LTD4 and LTE4, were studied in a non-recirculating rat liver perfusion system at constant flow in both antegrade (from the portal to the caval vein) and retrograde (from the caval to the portal vein) perfusion directions. During a 5-min infusion of [3H]LTC4,[3H]LTD4 and [3H]LTE4 (10 nmol/l each) in antegrade perfusions single-pass extractions of radioactivity from the perfusate were 66%, 81% and 83%, respectively. Corresponding values for LTC4 and LTD4 in retrograde perfusions were 83% and 93%, respectively, indicating a more efficient uptake of cysteinyl leukotrienes in retrograde than in antegrade perfusions. The concentrations of unmetabolized leukotrienes in the effluent perfusate were 8–12% in antegrade and 2–4% in retrograde perfusions. [14C]Taurocholate extraction from the perfusate was inhibited by LTC4 by only 3%, suggesting that an opening of portal-venous/hepatic-venous shunts does not explain the effects of perfusion direction on hepatic LTC4 uptake. 2 Following infusion of [3H]LTC4 and [3H]LTD4, in the antegrade perfusion direction, about 80% and 87%, respectively, of the radiolabel taken up by the liver was excreted into bile. In retrograde perfusions, however, only 40% and 57%, respectively, was excreted into bile and the remainder was slowly redistributed into the perfusate, indicating that leukotrienes were taken up into a hepatic compartment with less effective biliary elimination or converted to metabolites escaping biliary excretion. The metabolite pattern found in bile was not affected by the direction of perfusion. Biliary products of LTC4 were polar metabolites (31–38%), LTD4 (27–30%), LTE4 (about 1%) and N-acetyl-LTE4 (3–4%) in addition to unmodified LTC4 (17–18%). 3 LTC4 was identified as a major metabolite of [3H]LTD4 in bile, amounting to about 20% of the total radioactivity excreted into bile. This is probably due to a γ-glutamyltransferase-catalyzed glutamyl transfer from glutathione in the biliary compartment, as demonstrated in in vitro experiments. The presence of sinusoidal γ-glutamyltransferase activity in perfused rat liver was shown in experiments on the hydrolysis of infused γ-glutamyl-p-nitroanilide. 90% inhibition of this enzyme activity by AT-125 did not affect the metabolism of LTC4. 4 When [3H]LTE4 was infused in the antegrade perfusion direction, biliary metabolites comprised N-acetyl-LTE4 (24%) and polar components (60%). 5 The data show (a) that cysteinyl leukotrienes are effectively taken up and metabolized during a single liver passage, the metabolites being excreted into bile and released into perfusate; (b) zonal hepatocyte heterogeneities regarding leukotriene effector, uptake and biliary excretion sites are likely to exist; and (c) LTD4 in bile is converted to LTC4, suggesting also a biosynthetic function of canalicular or biliary γ-glutamyltransferase, at least in the experimental system of perfused rat liver." @default.
• W1483092803 created "2016-06-24" @default.
• W1483092803 creator A5008452332 @default.
• W1483092803 creator A5062646281 @default.
• W1483092803 creator A5071180693 @default.
• W1483092803 date "1989-04-01" @default.
• W1483092803 modified "2023-09-23" @default.
• W1483092803 title "Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion" @default.
• W1483092803 cites W1027352017 @default.
• W1483092803 cites W1502207890 @default.
• W1483092803 cites W1509897118 @default.
• W1483092803 cites W1516241516 @default.
• W1483092803 cites W1525534263 @default.
• W1483092803 cites W1535203254 @default.
• W1483092803 cites W1542751334 @default.
• W1483092803 cites W1601932687 @default.
• W1483092803 cites W1605053531 @default.
• W1483092803 cites W1969493478 @default.
• W1483092803 cites W1970141216 @default.
• W1483092803 cites W1971471687 @default.
• W1483092803 cites W1974852622 @default.
• W1483092803 cites W1987425357 @default.
• W1483092803 cites W1995956658 @default.
• W1483092803 cites W2002961420 @default.
• W1483092803 cites W2004351423 @default.
• W1483092803 cites W2027813069 @default.
• W1483092803 cites W2033021765 @default.
• W1483092803 cites W2036342256 @default.
• W1483092803 cites W2036545288 @default.
• W1483092803 cites W2037022310 @default.
• W1483092803 cites W2049065283 @default.
• W1483092803 cites W2054532226 @default.
• W1483092803 cites W2061393907 @default.
• W1483092803 cites W2061482508 @default.
• W1483092803 cites W2061538287 @default.
• W1483092803 cites W2066693601 @default.
• W1483092803 cites W2067330787 @default.
• W1483092803 cites W2067839662 @default.
• W1483092803 cites W2069075287 @default.
• W1483092803 cites W2069081720 @default.
• W1483092803 cites W2075603871 @default.
• W1483092803 cites W2095497606 @default.
• W1483092803 cites W2156723663 @default.
• W1483092803 cites W2322480835 @default.
• W1483092803 doi "https://doi.org/10.1111/j.1432-1033.1989.tb14701.x" @default.
• W1483092803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2565811" @default.
• W1483092803 hasPublicationYear "1989" @default.
• W1483092803 type Work @default.
• W1483092803 sameAs 1483092803 @default.
• W1483092803 citedByCount "29" @default.
• W1483092803 crossrefType "journal-article" @default.
• W1483092803 hasAuthorship W1483092803A5008452332 @default.
• W1483092803 hasAuthorship W1483092803A5062646281 @default.
• W1483092803 hasAuthorship W1483092803A5071180693 @default.
• W1483092803 hasConcept C10146269 @default.
• W1483092803 hasConcept C126322002 @default.
• W1483092803 hasConcept C134018914 @default.
• W1483092803 hasConcept C146957229 @default.
• W1483092803 hasConcept C185592680 @default.
• W1483092803 hasConcept C202751555 @default.
• W1483092803 hasConcept C2776042228 @default.
• W1483092803 hasConcept C2776200302 @default.
• W1483092803 hasConcept C2776452501 @default.
• W1483092803 hasConcept C2777477808 @default.
• W1483092803 hasConcept C2779389133 @default.
• W1483092803 hasConcept C2779543280 @default.
• W1483092803 hasConcept C55493867 @default.
• W1483092803 hasConcept C62231903 @default.
• W1483092803 hasConcept C71924100 @default.
• W1483092803 hasConcept C86803240 @default.
• W1483092803 hasConceptScore W1483092803C10146269 @default.
• W1483092803 hasConceptScore W1483092803C126322002 @default.
• W1483092803 hasConceptScore W1483092803C134018914 @default.
• W1483092803 hasConceptScore W1483092803C146957229 @default.
• W1483092803 hasConceptScore W1483092803C185592680 @default.
• W1483092803 hasConceptScore W1483092803C202751555 @default.
• W1483092803 hasConceptScore W1483092803C2776042228 @default.
• W1483092803 hasConceptScore W1483092803C2776200302 @default.
• W1483092803 hasConceptScore W1483092803C2776452501 @default.
• W1483092803 hasConceptScore W1483092803C2777477808 @default.
• W1483092803 hasConceptScore W1483092803C2779389133 @default.
• W1483092803 hasConceptScore W1483092803C2779543280 @default.
• W1483092803 hasConceptScore W1483092803C55493867 @default.
• W1483092803 hasConceptScore W1483092803C62231903 @default.
• W1483092803 hasConceptScore W1483092803C71924100 @default.
• W1483092803 hasConceptScore W1483092803C86803240 @default.
• W1483092803 hasIssue "1" @default.
• W1483092803 hasLocation W14830928031 @default.
• W1483092803 hasLocation W14830928032 @default.
• W1483092803 hasOpenAccess W1483092803 @default.
• W1483092803 hasPrimaryLocation W14830928031 @default.
• W1483092803 hasRelatedWork W1483092803 @default.
• W1483092803 hasRelatedWork W1653905423 @default.
• W1483092803 hasRelatedWork W1995712293 @default.
• W1483092803 hasRelatedWork W2002371011 @default.
• W1483092803 hasRelatedWork W2021846613 @default.
• W1483092803 hasRelatedWork W2022389305 @default.
• W1483092803 hasRelatedWork W2085850665 @default.

• next